ABALLI JOHN

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 24% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
7 43% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 116%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
ABALLI JOHN's trades of Exagen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-04 2026-03-03
US Exagen Inc (XGN)
S Sale
26,439 -26.3%
81.31
US$2,480,384 		26,439 -26.3% 81.31 US$2,480,384
2026-02-25 2026-02-24
US Exagen Inc (XGN)
S Sale
38,362 -30.5%
432.26
US$3,274,612 		38,362 -30.5% 432.26 US$3,274,612
2025-10-20 2025-10-16
US Exagen Inc (XGN)
S Sale
20,435 +36.2%
396.90
US$3,760,498 		20,435 +36.2% 396.90 US$3,760,498
2024-11-18 2024-11-14
US Exagen Inc (XGN)
B Purchase
24,305 +3.7%
2.81
US$68,297 		24,305 +3.7% 2.81 US$68,297
2024-05-16 2024-05-16
US Exagen Inc (XGN)
B Purchase
40,401 +inf%
1.92
US$77,570 		40,401 +inf% 1.92 US$77,570
2023-10-18 2023-10-17
US Exagen Inc (XGN)
S Sale
33,819 -7.5%
1.75
US$59,018 		33,819 -7.5% 1.75 US$59,018
2022-12-09 2022-12-08
US Exagen Inc (XGN)
B Purchase
90,000 +25.7%
2.68
US$241,200 		90,000 +25.7% 2.68 US$241,200